2015

1. Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years

   Arthritis and Rheumatology, Vol. 67, Núm. 10, pp. 2759-2770